卵巢癌中的T细胞受体治疗:概念和挑战
Xiaohan Wang1,2, Zhuoyao Li1,2, Mengwen Zhang1,2
1Department of Gynecologic Oncology, Gynecology and Obstetrics Centre, The First Hospital of Jilin University, Changchun, China.
Journal of ovarian research
|November 13, 2025
概括
T细胞受体 (TCR) 作为早期卵巢癌检测和新型免疫疗法的生物标志物具有前途. 研究探讨TCR结构,检测和应用在预测疾病和指导TCR-T细胞治疗卵巢癌.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 卵巢癌 (OC) 的死亡率和复发率很高,大多数患者的诊断是在晚期.
- 传统疗法面临药物耐药性和复发等挑战,需要新的治疗策略.
- 早期诊断和有效的卵巢癌查仍然是重要的未满足的临床需求.
研究的目的:
- 探索T细胞受体 (TCR) 作为早期卵巢癌诊断生物标志物的作用.
- 审查TCR结构,功能和检测技术.
- 讨论基于TCR的免疫疗法,特别是TCR-T细胞疗法,用于卵巢癌治疗.
主要方法:
- 关于T细胞受体生物学及其在瘤学中的应用的当前文献的综述.
- 对TCR谱系检测技术和免疫组织化学的分析.
- 检查基于TCR的疾病预测和免疫治疗策略.
主要成果:
- T细胞受体是抗原识别的核心,并显示出作为卵巢癌诊断生物标志物的潜力.
- 对TCR谱系分析提供了对疾病预测的见解.
- TCR-T细胞疗法代表了卵巢癌免疫治疗的有前途途途.
结论:
- 在卵巢癌的精准医学中,TCRs是至关重要的,有助于早期诊断和向免疫治疗.
- 对TCR检测和TCR-T细胞治疗的进一步研究对于克服卵巢癌治疗挑战至关重要.
- 基于TCR的方法具有显著的潜力,可以改善卵巢癌患者的治疗结果.
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Vaccines
939
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
939
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


